Evaluation of inclisiran versus placebo for the prevention of major adverse cardiovascular and limb events in patients undergoing percutaneous coronary intervention or peripheral endovascular intervention (VICTORION-INTERVENTION)
Clinical Trial Grant
Administered By
Surgery, Vascular and Endovascular Surgery
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
June 16, 2026
End Date
December 31, 2029
Administered By
Surgery, Vascular and Endovascular Surgery
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
June 16, 2026
End Date
December 31, 2029